/
/
/

Zydus Lifesciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹8017 Cr₹7587 Cr₹6865 Cr₹6123 Cr₹6574 Cr₹6528 Cr₹5269 Cr₹5237 Cr₹6208 Cr₹5534 Cr₹4505 Cr₹4369 Cr₹5140 Cr₹5011 Cr₹4257 Cr₹4006 Cr₹3964 Cr₹3806 Cr₹3640 Cr₹3760 Cr₹4025 Cr₹3670 Cr₹3796 Cr₹3659 Cr₹3515 Cr₹3752 Cr₹3638 Cr₹3367 Cr₹3496 Cr₹3733 Cr₹3578 Cr₹2961 Cr₹2894 Cr₹3238 Cr₹3260 Cr₹3222 Cr₹2235 Cr₹2513 Cr₹2364 Cr₹2404 Cr₹2333 Cr₹2387 Cr₹2359 Cr₹2351 Cr₹2383 Cr₹2288 Cr₹2205 Cr₹2108 Cr₹2050 Cr₹1969 Cr₹1872 Cr₹1747 Cr₹1637 Cr₹1612 Cr₹1604 Cr₹1548 Cr
₹106 Cr₹779 Cr₹111 Cr₹523 Cr₹155 Cr₹81 Cr₹58 Cr₹114 Cr₹63 Cr₹162 Cr₹38 Cr₹136 Cr₹36 Cr₹38 Cr₹144 Cr₹174 Cr₹174 Cr₹79 Cr₹61 Cr₹53 Cr₹32 Cr-₹30 Cr₹28 Cr₹28 Cr₹23 Cr₹44 Cr₹20 Cr₹27 Cr₹23 Cr₹38 Cr₹31 Cr₹30 Cr₹101 Cr₹44 Cr₹26 Cr₹23 Cr₹21 Cr₹73 Cr₹17 Cr₹24 Cr₹15 Cr₹39 Cr₹32 Cr₹20 Cr₹24 Cr₹20 Cr₹10 Cr₹15 Cr₹10 Cr₹13 Cr₹13 Cr₹12 Cr₹13 Cr₹9 Cr₹12 Cr₹6 Cr
₹8123 Cr₹8366 Cr₹6976 Cr₹6646 Cr₹6729 Cr₹6609 Cr₹5327 Cr₹5351 Cr₹6271 Cr₹5696 Cr₹4543 Cr₹4505 Cr₹5176 Cr₹5048 Cr₹4401 Cr₹4179 Cr₹4139 Cr₹3885 Cr₹3701 Cr₹3813 Cr₹4057 Cr₹3640 Cr₹3823 Cr₹3686 Cr₹3537 Cr₹3796 Cr₹3658 Cr₹3394 Cr₹3519 Cr₹3771 Cr₹3609 Cr₹2992 Cr₹2995 Cr₹3282 Cr₹3286 Cr₹3244 Cr₹2256 Cr₹2586 Cr₹2380 Cr₹2427 Cr₹2348 Cr₹2426 Cr₹2391 Cr₹2371 Cr₹2407 Cr₹2309 Cr₹2215 Cr₹2123 Cr₹2061 Cr₹1982 Cr₹1884 Cr₹1759 Cr₹1650 Cr₹1620 Cr₹1616 Cr₹1554 Cr
₹6642 Cr₹6186 Cr₹5408 Cr₹4823 Cr₹4723 Cr₹4640 Cr₹4111 Cr₹4055 Cr₹4339 Cr₹4114 Cr₹3598 Cr₹3489 Cr₹3814 Cr₹3934 Cr₹3588 Cr₹3501 Cr₹3420 Cr₹3273 Cr₹3065 Cr₹3038 Cr₹3275 Cr₹2996 Cr₹3169 Cr₹3020 Cr₹2897 Cr₹3139 Cr₹3114 Cr₹2903 Cr₹3009 Cr₹3078 Cr₹2892 Cr₹2421 Cr₹2391 Cr₹2527 Cr₹2548 Cr₹2491 Cr₹2080 Cr₹2163 Cr₹2049 Cr₹1978 Cr₹1894 Cr₹1913 Cr₹1841 Cr₹1813 Cr₹1874 Cr₹1868 Cr₹1813 Cr₹1760 Cr₹1742 Cr₹1663 Cr₹1626 Cr₹1538 Cr₹1398 Cr₹1373 Cr₹1403 Cr₹1361 Cr
₹2036 Cr₹2689 Cr₹1928 Cr₹2125 Cr₹2243 Cr₹2206 Cr₹1445 Cr₹1530 Cr₹2147 Cr₹1787 Cr₹1140 Cr₹1200 Cr₹1541 Cr₹1293 Cr₹995 Cr₹860 Cr₹899 Cr₹797 Cr₹812 Cr₹953 Cr₹965 Cr₹819 Cr₹834 Cr₹841 Cr₹813 Cr₹836 Cr₹718 Cr₹663 Cr₹681 Cr₹849 Cr₹871 Cr₹718 Cr₹746 Cr₹899 Cr₹884 Cr₹880 Cr₹298 Cr₹538 Cr₹421 Cr₹535 Cr₹539 Cr₹590 Cr₹624 Cr₹631 Cr₹602 Cr₹516 Cr₹473 Cr₹436 Cr₹387 Cr₹372 Cr₹308 Cr₹273 Cr₹298 Cr₹294 Cr₹264 Cr₹237 Cr
₹156 Cr₹123 Cr₹130 Cr₹101 Cr₹85 Cr₹77 Cr₹32 Cr₹25 Cr₹32 Cr₹35 Cr₹20 Cr₹9 Cr₹18 Cr₹28 Cr₹33 Cr₹35 Cr₹34 Cr₹39 Cr₹31 Cr₹30 Cr₹27 Cr₹23 Cr₹27 Cr₹45 Cr₹68 Cr₹83 Cr₹81 Cr₹90 Cr₹89 Cr₹77 Cr₹46 Cr₹36 Cr₹35 Cr₹15 Cr₹13 Cr₹41 Cr₹22 Cr₹10 Cr₹7 Cr₹15 Cr₹14 Cr₹16 Cr₹12 Cr₹13 Cr₹12 Cr₹16 Cr₹16 Cr₹17 Cr₹18 Cr₹24 Cr₹19 Cr₹19 Cr₹28 Cr₹32 Cr₹39 Cr₹41 Cr
₹1307 Cr₹1660 Cr₹1353 Cr₹1687 Cr₹1921 Cr₹1672 Cr₹1184 Cr₹1271 Cr₹1900 Cr₹1547 Cr₹926 Cr₹1007 Cr₹1329 Cr₹486 Cr₹780 Cr₹643 Cr₹681 Cr₹573 Cr₹604 Cr₹858 Cr₹755 Cr₹548 Cr₹627 Cr₹490 Cr₹573 Cr₹522 Cr₹457 Cr₹122 Cr₹394 Cr₹606 Cr₹672 Cr₹535 Cr₹570 Cr₹740 Cr₹724 Cr₹713 Cr₹154 Cr₹414 Cr₹324 Cr₹435 Cr₹441 Cr₹498 Cr₹537 Cr₹545 Cr₹519 Cr₹426 Cr₹375 Cr₹345 Cr₹300 Cr₹281 Cr₹236 Cr₹202 Cr₹223 Cr₹216 Cr₹174 Cr₹153 Cr
₹952 Cr₹1341 Cr₹965 Cr₹1233 Cr₹1487 Cr₹1249 Cr₹1004 Cr₹898 Cr₹1464 Cr₹1229 Cr₹734 Cr₹780 Cr₹1112 Cr₹346 Cr₹585 Cr₹511 Cr₹554 Cr₹449 Cr₹488 Cr₹3000 Cr₹636 Cr₹732 Cr₹513 Cr₹424 Cr₹470 Cr₹414 Cr₹364 Cr₹83 Cr₹315 Cr₹479 Cr₹513 Cr₹410 Cr₹449 Cr₹580 Cr₹543 Cr₹501 Cr₹125 Cr₹410 Cr₹316 Cr₹370 Cr₹386 Cr₹561 Cr₹446 Cr₹467 Cr₹447 Cr₹355 Cr₹296 Cr₹288 Cr₹247 Cr₹246 Cr₹195 Cr₹192 Cr₹203 Cr₹275 Cr₹111 Cr₹103 Cr

Share Price Live Stats

Open (₹)1,146.00
Volume (₹)2.07 L
High (₹)1,146.00
Upper Circuit1,257.30
Low (₹)1,125.10
Lower Circuit1,028.70
Prev Close1,143.00
52W High (₹)1,205.00
Price1,133.80
52W Low (₹)835.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)113217.00 Cr
Div. Yield (%)0.09
PE Ratio25.09
Debt to Equity0.43
Price to Book3.23
Book Value269.50
EPS (TTM)45.24
Face Value1.00
ROE (%)19.69

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1905.8-14.2 (-0.74%)
1902
1984.80
4,56,833Cr
9216-23 (-0.25%)
9087
9467
2,45,426Cr
4892-158 (-3.13%)
4885
5066
1,87,320Cr
1133.8-57.2 (-4.80%)
1125.10
1187
1,13,217Cr
1391.6-31.9 (-2.24%)
1376.70
1426.10
1,12,212Cr
1853.9-84.6 (-4.36%)
1811.70
1949
1,01,155Cr
2127-44.5 (-2.05%)
2118.10
2192
97,626Cr
2350.6-32.3 (-1.36%)
2341.20
2419.20
96,859Cr
1164.1-13.9 (-1.18%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr

Key Highlights of Zydus Lifesciences Ltd’s P&L

In 2026-03-31, Zydus Lifesciences Ltd reported total revenue of ₹28943Cr, compared with ₹23701.1Cr in 2025-03-31, reflecting Zydus Lifesciences Ltd turnover.

Depreciation was ₹1408Cr and finance costs were ₹438.9Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹6621.1Cr in 2026-03-31 as compared to ₹6026.7Cr in 2025-03-31.

Net Profit (PAT) was ₹5040Cr in 2026-03-31 compared with ₹4525.5Cr in 2025-03-31.

Earnings per share (EPS) were ₹50.10 in 2026-03-31, compared with ₹44.99 in 2025-03-31.